09.29.26 -- You Can't CAPA What You Can't Classify

Explore the factors to consider when weighing the options and the range of technologies available to meet your quality, production, and ROI requirements.

Aseptic pouching requires specialized mechanical segregation and sterile vacuum handling. Discover how targeted engineering maintains Grade A compliance.

Standard automation can handle individual tasks, but complex assays often need more flexibility. Learn how customization helps labs connect systems, adapt workflows, and build automation strategies.

Whether you are just entering the peptide market or scaling an established product, access to a reliable supply of high-quality building blocks is critical to running a successful peptide program.

Gain insight into how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.

Scientific workflows are no longer confined to one device. Cross-platform access to analytical data is becoming essential, helping researchers stay productive and collaborate more effectively.

Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.

As drug pipelines shift toward smaller, more complex therapies, portable bioprocessing tools are helping teams reduce delays, improve data integrity, and enable flexible manufacturing.

Effective drug substance handoff to fill-finish manufacturing depends on early collaboration, clear communication, and proactive planning to reduce risks, ensure quality, and maintain timelines.

Technology transfer connects drug development to manufacturing through early engagement, open knowledge sharing, and data-driven methods like Design of Experiments to safely advance therapies.

Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.

Japan's market demands J-DMF registration, Foreign Manufacturer Accreditation, and GMP compliance. Find out how CDMO support simplifies PMDA submissions and accelerates market entry.

Uncover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.

Observe how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.

Transitioning from episodic audit prep to continuous readiness protects clinical timelines. Evaluate your quality operating model to support scalable growth today.

Early planning for scale-up and biologics license application activities can maximize your chances of success by allowing sufficient time to develop launch options and prevent costly delays and setbacks.

Combine quantitative enzyme indicators, computational fluid dynamics, and traditional biological indicators to improve VPHP isolator validation and process confidence.

See how tiered automation platforms resolve cell therapy manufacturing bottlenecks, enabling a seamless transition from clinical trials to high-volume commercial supply.

Take a look at how understanding the transport phenomenon in the boundary layer can allow us to engineer the flow to manage the rate-limiting step and intensify the process.

Master USP <800> compliance by transitioning from standalone equipment to an integrated system design. Review key protocols for a multi-layered strategy to mitigate cumulative drug risks.